semaglutide and cardiovascular outcomes in obesity VisualAbstract: Improves Patients with Obesity-Related Heart Failure Type 2 Diabetes Obesity: a therapeutic target in

J Mol Med (Berl) 2017;95:323333

A 2012 meta-analysis, in fact, demonstrated that on average patients with ASD had a 27% lower plasma concentration of GSH with corresponding 45% higher plasma levels of reduced GSH (GSSG) when compared to health controls (127)

Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, Keogh JM, Yanovski JA, El Gharbawy A, Han JC, Tung YC, Hodges JR, Raymond FL, O'Rahilly S, Farooqi IS

Core Comparison: Small molecules lead in convenience and cost efficiency, but face drawbacks including harsher gastrointestinal side effects, unvalidated long-term safety profiles, and limited multi-target development potential